Nestlé tackling new opportunity in emerging Food & Pharma industry, Focus Reports
Release Date: 2010-11-29
Swiss multinational Nestlé has decided to pioneer into the food and pharma market by creating its own subsidiary entirely dedicated to health sciences. The new division will be larger than the already existing Nestlé Healthcare Nutrition business which will be incorporated into the larger structure. The decision to create the new Nestle Health Science segment was announced back in late September, even though the business will only become operational as of January 1st, 2011. The new division will headed run by Luis Cantarell who is currently the CEO of the Americas division for Nestlé worldwide, which is in fact the largest market for the company’s global operation. The new business will take advantage of the scientific know-how and technological expertise of the Nestlé group through several venture capital funds in which the consumer goods giant has interests.
Together with the creation of the Nestlé Health Science division, the company announced that it will establish the Nestlé Institute of Health that will function as the R&D unit of the Health Science business. As part of the Nestle R&D network, the institute will focus on conducting biomedical science research providing its results to the nutritional business with the goal of improving health and quality of life.
By creating these two new entities Nestlé expects to ensure a privileged position in what they consider, from the strategic point of view, a “promising business opportunity for the future” as the CEO Paul Bulcke affirms in the company’s press release related to the event. The initiative falls under the umbrella of Nestlé’s vision “Good food, good life” and is meant to help the multinational become the leader in the innovative personalized area of science nutrition. The company plans to use the subsidiary in order to develop nutritional products that will prevent and treat health issues such as obesity, diabetes, Alzheimer and cardiovascular disease.
Peter Brabeck-Letmathe, the current Chairman of the company is confident that tackling this market opportunity is a logical consequence of the company’s development strategy. It is his view that “the combination of health economics, changing demographics and advances in health science show that our existing healthcare systems, which focus on treating sick people, are not sustainable and need redesigning. Nestlé has the expertise, the science, the resources and the organisation to play a major role in seeking alternative solutions. Personalised health science nutrition is about finding efficient and cost effective ways to prevent and treat acute and chronic diseases in the 21st century.”
Nestlé, is a Swiss company with headquarters in Vevey, is the leading multinational in nutrition, health and wellness employing more than 280,000 people all over the world. It entered the healthcare nutrition business back in 1986 and has recently bought Novartis Medical Nutrition among several other acquisitions in the field.
| Type: | NORMAL |
| Company: | Focus Reports |
| Country: | 瑞士 |